https://forefrontadvisers.com/mythos-opens-up-new-lines-of-debate/ 2026-05-12T12:52:36Z Forefront en Mythos opens up new lines of debate 2026-05-12T12:48:51Z Blog https://forefrontadvisers.com/biotech-act-ii-remains-poorly-defined/ 2026-05-12T12:16:49Z Forefront en Biotech Act II remains poorly defined 2026-05-12T10:28:33Z Blog